Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobradex BID vs Tobradex and Tobrex in Post-surgical Inflammation
NCT00404937Phase 3Withdrawn
- Sponsor
- Alcon Inc.
- Start
- Dec 2006
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of tobramycin + dexamethasone in inflammation, sponsored by Alcon Inc.. Planned start Dec 2006; status: withdrawn.
02
Drugs
tobramycin + dexamethasone
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT00404937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404937.